{
  "node": {
    "slug": "type-2-diabetes",
    "network": "t2d_trials",
    "title": "Type 2 diabetes trials",
    "description": "Recruiting type 2 diabetes studies from ClinicalTrials.gov, with eligibility criteria structured for private pre-screening."
  },
  "disclaimer": "Demo node, not a real trial site; pre-screening only, not medical advice.",
  "source": {
    "name": "ClinicalTrials.gov",
    "url": "https://clinicaltrials.gov/",
    "retrieved": "2026-11-16",
    "modified": "Fields selected and summaries shortened by ChartStays; eligibility criteria structured and coded. Each study links to its authoritative ClinicalTrials.gov record."
  },
  "studies": [
    {
      "nct_id": "NCT07272343",
      "title": "The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes",
      "status": "RECRUITING",
      "conditions": [
        "Type 2 Diabetes Mellitus (T2DM)",
        "Semaglutide",
        "Caloric Restriction"
      ],
      "phases": [
        "PHASE4"
      ],
      "sponsor": "Second Affiliated Hospital of Nanchang University",
      "summary": "To evaluate the effects of subcutaneous injection of semaglutide for 12 weeks on patients with type 2 diabetes mellitus (T2DM), compared with concurrent energy-restricted management, on glycemic control, weight loss, inflammatory markers, liver fat content, and other parameters. The study also observed the subcutaneous and visceral fat of the participants and explored the molecular mechanisms of…",
      "url": "https://clinicaltrials.gov/study/NCT07272343",
      "last_update_posted": "2026-04-02",
      "criteria": "./criteria/NCT07272343.json",
      "logistics": "./logistics/NCT07272343.json",
      "structured_criteria": 5,
      "free_text_criteria": 9
    },
    {
      "nct_id": "NCT07390422",
      "title": "Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease",
      "status": "RECRUITING",
      "conditions": [
        "T2DM (Type 2 Diabetes Mellitus)",
        "MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease",
        "Metabolic Syndrome (MetS)"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Chinese University of Hong Kong",
      "summary": "This study is designed to evaluate the efficacy, safety, and mechanisms of pulsENDO procedure in patients with T2DM and its effect on MASLD.",
      "url": "https://clinicaltrials.gov/study/NCT07390422",
      "last_update_posted": "2026-09-15",
      "criteria": "./criteria/NCT07390422.json",
      "logistics": "./logistics/NCT07390422.json",
      "structured_criteria": 7,
      "free_text_criteria": 23
    },
    {
      "nct_id": "NCT06627322",
      "title": "A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)",
      "status": "RECRUITING",
      "conditions": [
        "Type 2 Diabetes"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Kyu Chang Won",
      "summary": "Glycemic control is a mainstay of diabetes management to reduce the risk of microvascular complications and cardiovascular outcomes in people with type 2 diabetes (T2D). However, intensive control to near-normal glycated hemoglobin (HbA1c) yielded complex results in previous landmark trials. Potential risks of intensive glycemic control, such as hypoglycemia and weight gain, may partly contribute…",
      "url": "https://clinicaltrials.gov/study/NCT06627322",
      "last_update_posted": "2025-04-24",
      "criteria": "./criteria/NCT06627322.json",
      "logistics": "./logistics/NCT06627322.json",
      "structured_criteria": 5,
      "free_text_criteria": 20
    },
    {
      "nct_id": "NCT06875193",
      "title": "DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes",
      "status": "RECRUITING",
      "conditions": [
        "Type2diabetes"
      ],
      "phases": [
        "PHASE4"
      ],
      "sponsor": "Dong Wha Pharmaceutical Co. Ltd.",
      "summary": "Key finding of DM Treatment with combination, A MuLticenter, Randomized, Parallel, Gathering Information of phase 4 Trial to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone add-on to Metformin and DPP-4 inhibitor in Patients with Type 2 Diabetes Who Have Inadequate Glycaemic Control on a Background Combination of Metformin and DPP-4 inhibitor(KLIMT Study)",
      "url": "https://clinicaltrials.gov/study/NCT06875193",
      "last_update_posted": "2025-03-17",
      "criteria": "./criteria/NCT06875193.json",
      "logistics": "./logistics/NCT06875193.json",
      "structured_criteria": 9,
      "free_text_criteria": 27
    },
    {
      "nct_id": "NCT07007676",
      "title": "Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes",
      "status": "RECRUITING",
      "conditions": [
        "Diabetes Mellitus Type 2"
      ],
      "phases": [
        "NA"
      ],
      "sponsor": "Shanghai 6th People's Hospital",
      "summary": "The goal of this clinical trial is to learn if continuous glucose monitoring system works to improve glucose control in non-insulin-treated older adults with type 2 diabetes. The main questions it aims to answer are: * Dose the use of continuous glucose monitoring system improve glucose control in older adults with type 2 diabetes treated with oral antidiabetic drugs only? * Dose the use of conti…",
      "url": "https://clinicaltrials.gov/study/NCT07007676",
      "last_update_posted": "2026-09-08",
      "criteria": "./criteria/NCT07007676.json",
      "logistics": "./logistics/NCT07007676.json",
      "structured_criteria": 5,
      "free_text_criteria": 12
    }
  ]
}
